Hai-Jui Chu

Hai-Jui Chu

Auto-generated profile, based on publicly available information

Hai-Jui Chu

Department of Neurology, En Chu Kong Hospital, New Taipei City, Taiwan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2019 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
HCHai-Jui Chu
Hai-Jui Chu
CLChun-Hsien Lin
Chun-Hsien Lin
CCChih-Hao Chen
Chih-Hao Chen
YHYi Ting Hwang
Yi Ting Hwang
MLMeng Lee
Meng Lee
JJJiann-Shing Jeng
Jiann-Shing Jeng
Background and purpose Studies have suggested that blood pressure (BP) levels after endovascular thrombectomy (EVT) are correlated with clinical outcomes. The aim of our study was to investigate the effect of BP in different time intervals within the first 24 hours after EVT on functional outcomes. Methods Data of patients who received EVT for acute ischemic stroke at two institutions were reviewed. After EVT, hourly BP data were collected and divided into four time intervals: 1–6 hours, 7–12 hours, 13–18 hours, and 19–24 hours. The mean, maximum, and standard deviation (SD) of BP were calculated and compared with the outcome of interest in patients with successful recanalization. The outcome of interest was functional independence, which was defined as a 3-month modified Rankin Scale score of ≤2. Results Of 224 patients with stroke who received EVT, 166 (74.1%) (mean age 70.2±13.1 years; 49.4% men) achieved successful recanalization and 82 (49.4%) exhibited functional independence. After adjustment for possible confounders, lower mean, maximum, and SD values of systolic and diastolic BP observed in the first 6 hours after EVT were independently associated with functional independence. Furthermore, the area under the receiver operating characteristic curve values observed for BP parameters for outcome prediction in the first 6 hours were the highest across the 24-hour period following EVT. Conclusion In patients with stroke who achieved successful recanalization, the first 6 hours after EVT was the key period influencing the correlation between BP and functional outcome.

1 September 2018 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
HCHai-Jui Chu
Hai-Jui Chu
STSung-Chun Tang
Sung-Chun Tang
CLCHUNG-WEI LEE
CHUNG-WEI LEE
JJJiann-Shing Jeng
Jiann-Shing Jeng
HLHon-Man Liu
Hon-Man Liu
Endovascular thrombectomy has been strongly recommended for treatment of acute ischemic stroke (AIS) with large vessel occlusion. This study aimed to evaluate its efficacy and safety in an Asian population from a single center in Taiwan. Patients who experienced AIS and received endovascular thrombectomy during the period of September 2014 to September 2016 at National Taiwan University Hospital were included. Factors related to favorable outcome, defined as modified Rankin scale 0-2 at 90 days after stroke, were analyzed. During the study period, 65 patients (mean age, 71.9 ± 12.4 years; 44.6% females) received endovascular thrombectomy, including 33 who received intravenous thrombolysis before the endovascular treatment. A significant trend of increasing thrombectomy therapy was observed. The median National Institutes of Health Stroke Scale (NIHSS) score on admission was 19 (interquartile range, 15-26). The sites of vessel occlusion were middle cerebral artery in 47 (72.3%) patients, intracranial internal carotid artery in 8 (12.4%), anterior cerebral artery in 1 (1.5%), and basilar artery in 9 (13.8%). The median times from stroke onset to groin puncture and from groin puncture to recanalization time were 200 and 29.5 min, respectively. Successful revascularization was achieved in 41 (63.1%) patients. Two (3.1%) patients had symptomatic hemorrhagic transformation. At 90 days, 25 (38.5%) patients achieved favorable outcome. A shorter time from onset to puncture, and successful recanalization were independent predictors of favorable outcome. This study demonstrated the therapeutic promise of endovascular thrombectomy for treatment of AIS with large vessel occlusion in a clinical setting.

1 January 2021 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
CLChi-Ju Lu
Chi-Ju Lu
YLYen-Heng Lin
Yen-Heng Lin
HCHai-Jui Chu
Hai-Jui Chu
STSung-Chun Tang
Sung-Chun Tang
CLCHUNG-WEI LEE
CHUNG-WEI LEE
The transbrachial approach (TBA) is an alternative method to the transfemoral approach (TFA). We herein aimed to evaluate the safety and efficacy of the TBA for endovascular thrombectomy (EVT) in patients with acute large vessel occlusion stroke. We reviewed the records of 297 patients who had undergone EVT from January 2015 to July 2019. Eighteen patients who had undergone 19 procedures were included. Indications for arterial access, devices, recanalization rates, complication rates, and clinical outcomes were evaluated. There were 15 and 4 cases of anterior and posterior circulation stroke, respectively. The mean patient age was 80.1 years. Eight patients were male. The median National Institutes of Health Stroke Scale score was 18. The total procedure duration tended to be longer when the TBA was used after failure of the TFA (n = 6, 32%, median: 60.5 min) than when the TBA was used as the first treatment approach (n = 13, 68%, median: 22 min). Optimal recanalization (a modified Thrombolysis in Cerebral Infarction score of 2b or 3) was achieved for 15 procedures. Local complications were observed in two cases: one with brachial artery pseudoaneurysm and another with brachial artery occlusion. Three patients with anterior circulation stroke exhibited good clinical outcomes (modified Rankin score ≤ 2) at 90 days. Symptomatic intracranial hemorrhage occurred in one patient. Mortality was noted in four patients. The TBA for EVT is a suitable alternative when adoption of the TFA is difficult or impossible.

9 December 2025 in Neurology
Verified
Journal Article
Closed access
CCChih-Hao Chen
Chih-Hao Chen
YKYong Soo Kim
Yong Soo Kim
CLChung-Wei Lee
Chung-Wei Lee
CCChung Liang Chai
Chung Liang Chai
YHYi-Chen Hsieh
Yi-Chen Hsieh
AIas the TREAT-AIS and CRCS-K investigators
as the TREAT-AIS and CRCS-K investigators
The role of IV thrombolysis before endovascular thrombectomy (bridging thrombectomy, BT) in posterior circulation large-vessel occlusion stroke remains uncertain. This study evaluated the effectiveness and safety of BT compared with direct thrombectomy (DT) using data from 2 nationwide registries and an updated meta-analysis. Patients from collaborative registries in Taiwan and South Korea who underwent thrombectomy for vertebral, basilar, and posterior cerebral artery occlusions were included. This observational study included hospital-based registry data with standardized collection of treatments and outcomes. Propensity score matching was applied to adjust for baseline differences between BT and DT groups. Outcomes included 90-day modified Rankin Scale (mRS) score, mortality, successful reperfusion, and symptomatic intracranial hemorrhage (sICH). We also performed a systematic review and meta-analysis of observational studies comparing BT vs DT in posterior circulation large-vessel occlusion stroke. Among the combined 9,942 patients, 873 (median age 71, 32% female) who underwent thrombectomy for posterior circulation stroke were analyzed. Of them, 281 received BT and 592 received DT. BT was associated with a lower 90-day mRS score (median 3 vs 4; adjusted odds ratio [OR] 1.44 per 1-point improvement, 95% CI 1.09-1.91) and lower mortality (17.4% vs 26.9%; adjusted OR 0.51, 95% CI 0.33-0.81). The proportions of successful reperfusion (79.3% vs 81.1%) and sICH (2.5% vs 2.9%) were comparable. In propensity score-matched cohorts (n = 205 each), BT remained associated with better functional outcomes (OR 1.44, 95% CI 1.00-2.07) and reduced mortality (matched OR 0.45, 95% CI 0.26-0.78). The meta-analysis, which included 39 studies and 7,288 patients, confirmed that BT was associated with higher odds of achieving 90-day mRS score 0-2 (OR 1.57, 95% CI 1.28-1.94), 90-day mRS score 0-3 (OR 1.33, 95% CI 1.05-1.68), and lower mortality (OR 0.77, 95% CI 0.61-0.97), without an increased risk of sICH (OR 1.01, 95% CI 0.71-1.44). BT was associated with better 90-day functional outcomes and lower mortality, without increasing hemorrhagic risk in posterior circulation large-vessel occlusion stroke. These findings support the use of BT in eligible patients, pending further validation from randomized trials. This study provides Class III evidence that in patients with posterior circulation stroke undergoing thrombectomy, previous IV thrombolysis is associated with better 90-day functional outcomes and lower mortality without increasing hemorrhagic risk.

1 September 2025 in Stroke
Verified
Journal Article
Closed access
Beomjoon KimBeomjoon Kim
Beomjoon Kim
STSung-Chun Tang
Sung-Chun Tang
YHYi-Chen Hsieh
Yi-Chen Hsieh
CCChih-Hao Chen
Chih-Hao Chen
YKYong Soo Kim
Yong Soo Kim
JJJiann-Shing Jeng
Jiann-Shing Jeng
BACKGROUND: As populations age, there is an increasing need to optimize endovascular treatment (EVT) and to understand country-specific differences in East Asia. We harmonized stroke registries from Korea and Taiwan to enable comparisons of patient characteristics and outcomes, with a particular focus on the impact of age. METHODS: Multicenter prospective stroke registries in Korea (CRCS-K [Clinical Research Collaboration for Stroke in Korea]) and Taiwan (TREAT-AIS [Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke]) were harmonized to form a unified data set of patients undergoing EVT. Outcomes included 3-month modified Rankin Scale, symptomatic intracranial hemorrhage, and successful recanalization. We assessed the association between age and outcomes in the overall population and those who were aged ≥80 years using logistic regression models, adjusting for relevant covariates. RESULTS: A total of 9934 EVT cases (7835 from Korea and 2099 from Taiwan) were included from 2011 to 2023. Patients had a mean age of 70.1±12.9 years (57.6% male; median National Institutes of Health Stroke Scale score, 14 [interquartile range, 9–19]). Compared with Korean patients, Taiwanese patients had a higher prevalence of risk factors and more severe strokes, contributing to lower rates of favorable 3-month outcomes. Increasing age was associated with poorer EVT results; among patients ≥80 years, 18% achieved a modified Rankin Scale score of 0 to 2, compared with 46% of younger patients. However, the risk of symptomatic intracranial hemorrhage did not significantly increase with age (adjusted odds ratio per year, 1.01 [0.99–1.02]; adjusted odds ratio of ≥80 years, 0.98 [0.75–1.29]). Prestroke functional independence, baseline hemoglobin, and bridging thrombolysis were identified as significant modifiers of outcomes in the oldest patients. CONCLUSIONS: Taiwanese EVT patients had more risk factors and worse outcomes than Korean patients. Advanced age is associated with poorer functional recovery, yet selected older patients, particularly those who were functionally independent before the stroke or received bridging thrombolysis, demonstrated meaningful benefit. These results underscore the importance of individualized treatment strategies and careful patient selection, especially as populations continue to age.

28 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
CCChang-Jie Cheng
Chang-Jie Cheng
YCYa-Hui Chang
Ya-Hui Chang
YSYu Sun
Yu Sun
HCHai-Jui Chu
Hai-Jui Chu
CLChun-Yu Lee
Chun-Yu Lee
Chung-Yi LiChung-Yi Li
Chung-Yi Li
Objective Large clinical trials have proved the efficacy of Covid-19 vaccine, and the number of literature about the effectiveness is rapidly growing in the first half of year after mass vaccination was administrated globally. This rapid review aims to provide evidence syntheses as a means to complement the current evidence on the vaccine effectiveness (VE) against various outcomes in real-world settings. Methods This review is conducted based on the updated guideline of PRISMA 2020. Databases (PubMed, EMBASE, and MedRxiv) were searched up to 30 June 2021, (PROSPERO ID: 266866). The studies that assessed the VE of the 6 WHO-authorized vaccines (BNT162b2, ChAdOx1, Ad26.COV2.S, mRNA-1273, BBIBP-CorV, and CoronaVac) were eligible to be included. Quality assessment was performed based on ROBINS-I by 2 independent reviewers. Findings A total of 39 studies were included, covering over 15 million of participants from 11 nations. Among the general population after 2 doses of vaccination, the VE against symptomatic SARS-CoV-2 infection was estimated at 89%–97%, 92% (95% CI, 78%–97%) and 94% (95% CI, 86%–97%) for BNT162b2, ChAdOx1 and mRNA-1273, respectively. As for the protective effects against B.1.617.2 related symptomatic infection, the VE was 88% (95% CI, 85.3%–90.1%) by BNT162b2 and 67.0% (95% CI, 61.3%–71.8%) by ChAdOx1 after fully vaccination. Conclusion This review revealed a consistently high effectiveness of vaccines among the general population in real-world settings. Further studies are needed to provide the information on different races/ethnicity, the effects against SARS-CoV-2 variants, and the duration of protection with longer study time.